Diabetology | Free Full-Text | Novel Insights into the Immunotherapy-Based Treatment Strategy for Autoimmune Type 1 Diabetes
Retraining the immune system to fight type 1 diabetes | Diabetes UK
Immunotherapy of type 1 diabetes: where are we and where should we be going? | Semantic Scholar
The challenge of modulating β-cell autoimmunity in type 1 diabetes - The Lancet Diabetes & Endocrinology
Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review in: European Journal of Endocrinology Volume 181 Issue 3 (2019)
Frontiers | Peptide Immunotherapy for Type 1 Diabetes—Clinical Advances
Targeting proinsulin to local immune cells using an intradermal microneedle delivery system; a potential antigen-specific immunotherapy for type 1 diabetes - ScienceDirect
Immunotherapy for Type 1 Diabetes: Why Do Current Protocols Not Halt the Underlying Disease Process? - ScienceDirect
A Landmark Trial Establishes The Safety Of Immunotherapy In Type 1 Diabetes
Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes | Nature Reviews Immunology
New immunotherapy trials could help people with type 1 diabetes - Diabetes Australia
Immunotherapy Safe for Diabetes 1? - 2017 - Wiley Analytical Science
Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?) | Nature Reviews Endocrinology
Frontiers | Approaches in Immunotherapy, Regenerative Medicine, and Bioengineering for Type 1 Diabetes
Immunotherapy for type 1 diabetes: what's in the pipeline? - The Pharmaceutical Journal
Diabetology | Free Full-Text | Novel Insights into the Immunotherapy-Based Treatment Strategy for Autoimmune Type 1 Diabetes
Antigen-specific therapy against Type 1 diabetes: mechanisms and perspectives | Immunotherapy
Collaborative Focused On Immunotherapy In Type 1 Diabetes – ANZ First | ATIC
Immunotherapy: Building a bridge to a cure for type 1 diabetes | Science
Approaches in the Treatment of Type 1 Diabetes Mellitus | EMJ Reviews
Immunotherapy in Autoimmune Type 1 Diabetes | The Review of Diabetic Studies
Immunotherapy of Type 1 Diabetes: Where Are We and Where Should We Be Going? - ScienceDirect
Experimental immunotherapy significantly delays onset of type 1 diabetes
